Table 2.
VEGF165 standards (ng/L) | VEGF165:bevacizumab molar ratio | VEGF165 concentrations (ng/L) |
---|---|---|
1000 | 1:0 | 1120.2 (2.67) |
1:0.1 | 448.5 (1.66) | |
1:1 | 452.2 (0.83) | |
1:1000 | 0 (0) | |
250 | 1:0 | 172.4 (4.33) |
1:0.1 | 79.1 (4.72) | |
1:1 | 79.1 (4.72) | |
1:1000 | 0 (0) |
VEGF165 concentrations are expressed as average (RSE %)